A novel computational approach to integrate NMR spectroscopy and capillary electrophoresis for structure assignment of heparin and heparan sulfate oligosaccharides

Glycobiology

Volumn 12, Issue 11, 2002, Pages 713-719

  Guerrini, Marco ^a   Raman, Rahul ^b   Venkataraman, Ganesh ^b   Torri, Giangiacomo ^a   Sasisekharan, Ram ^b   Casu, Benito ^a  

^a Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Capillary electrophoresis; Heparin oligosaccharides; Nuclear magnetic resonance; Property encoded nomenclature

Indexed keywords

ANTICOAGULANT AGENT; ENZYME; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYSACCHARIDE;

ANTICOAGULATION; ARTICLE; BINDING AFFINITY; CAPILLARY ELECTROPHORESIS; CARBOHYDRATE ANALYSIS; CELL GROWTH; CELL INVASION; CELL MATURATION; CELL SURFACE; COMPUTER ANALYSIS; CONTROLLED STUDY; METHODOLOGY; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PURIFICATION; SENSITIVITY AND SPECIFICITY; STRUCTURE ACTIVITY RELATION; VIRUS;

CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; ELECTROPHORESIS, CAPILLARY; HEPARIN; HEPARITIN SULFATE; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0036868807     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwf084     Document Type: Article

References (39)

1. Bourin, M.-C. and Lindahl, U. (1993) Glycosaminoglycans and the regulation of blood coagulation. Biochem. J., 289, 313-330.
2. Breddin, H.K. (2000) Prophylaxis and treatment of deep-vein thrombosis. Semin. Thromb. Hemost., 26, 47-52.
3. Casu, B. and Torri, G. (1999) Structural characterization of low molecular weight heparins. Semin. Thromb. Hemost., 25, 17-25.
4. Casu, B. and Lindahl, U. (2001) Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem., 57, 159-208.
5. Casu, B., Guerrini, M., Naggi, A., Torri, G., De-Ambrosi, L., Boveri, G., Gonella, S., Cedro, A., Ferro, L., Lanzarotti, E., and others. (1996) Characterization of sulfation patterns of beef and pig mucosal heparins by nuclear magnetic resonance spectroscopy. Arzneim-forsch (Drug Res.), 46, 472-477.
6. Chen, Y., Maguire, T., Hileman, R.E., Fromm, J.R., Esko, J.D., Linhardt, R.J., and Marks, R.M. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate [see comments]. Nat. Med., 3, 866-871.
7. Chuang, W.L., Christ, M.D., and Rabenstein, D.L. (2001) Determination of the primary structures of heparin- and heparan sulfate-derived oligosaccharides using band-selective homonuclear-decoupled two-dimensional 1H NMR experiments. Anal. Chem., 73, 2310-2316.
8. Cohen, M. (1999) Low molecular weight heparins in the management of unstable angina/non- Q-wave myocardial infarction. Semin. Thromb. Hemost., 25, 113-121.
9. 13C nuclear magnetic resonance spectroscopy. Carbohydr. Res., 255, 194-198.
10. Fry, E.E., Lea, S.M., Jackson, T., Newman, J.W., Ellard, F.M., Blakemore, W.E., Abu-Ghazaleh, R., Samuel, A., King, A.M., and Stuart, D.I. (1999) The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J., 18, 543-554.
11. 13C-NMR spectroscopy for characterization of heparin preparations. Semin. Thromb. Hemost., 274, 100-123.
12. Hricovini, M., Guerrini, M., and Torri, G. (1999) Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts. Eur. J. Biochem., 261, 789-801
13. Hricovini, M., Guerrini, M., Bisio, A., Torri, G., Petitou, M., and Casu, B. (2001) Conformation of heparin pentasaccharide bound to antithrombin III. Biochem. J., 359, 265-272.
14. Hulett, M.D., Freeman, C., Hamdorf, B.J., Baker, R.T., Harris, M.J., and Parish, C.R. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis [see comments]. Nat. Med., 5, 803-809.
15. Kay, L.E., Keifer, P., and Saaringen, T. (1992) Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc., 114, 10663-10665.
16. Kreuger, J., Salmivirta, M., Sturiale, L., Giménez-Gallego, G., and Lindahl, U. (2001) Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factoirs 1 and 2. J. Biol. Chem., 276, 30744-30752.
17. Lindahl, U. (2000) Heparin-from anticoagulant drug into the new biology. Glycoconj. J., 17, 597-605.
18. Linhardt, R.J. and Toida, T. (1999). Capillary electrophoresis of oligosaccharides and complex carbohydrates. In Honda, S. and Thibaull, P. (eds.), Characterization of glycosaminoglycans by capillary electrophoresis. Humana Press.
19. Liu, D., Shriver, Z., Venkataraman, G., El Shabrawi, Y., and Sasisekharan, R (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl Acad. Sci. USA, 99, 568-573.
20. Mulloy, B. and Johnson, E.A. (1987) Assignment of the 1H-n.m.r. spectra of heparin and heparan sulphate. Carbohydr. Res., 170, 151-165.
21. Neville, G.A., Mori, F., Holme, K.R., and Perlin, A.S. (1989) Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-nuclear magnetic resonance spectroscopy. J. Pharm. Sci., 78, 101-104.
22. Petitou, M., Herault, J.P., Bernat, A., Driguez, P.A., Duchaussoy, P., Lormeau, J.C., and Herbert, J.M. (1999) Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature, 398, 417-422.
23. Pope, R.M., Raska, C.S., Thorp, S.C., and Liu, J.A. (2001) Analysis of heparan sulfate oligosaccharides by nano-electrospray ionization mass spectrometry. Glycobiology, 11, 505-513.
24. Rosenberg, R.D. (2001) Redesigning heparin. N. Engl. J. Med., 344, 673-675.
25. Sasisekharan, R. and Venkataraman, G. (2000) Heparin and heparan sulfate: biosynthesis, structure and function. Curr. Opin. Chem. Biol., 6, 626-631.
26. Sasisekharan, R., Ernst, S., and Venkataraman, G. (1997) On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis, 1, 45-54.
27. Shriver, Z., Liu, D., and Sasisekharan, R. (2002) Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. Trends Cardiovasc. Med., 12, 71-77.
28. Shriver, Z., Raman, R., Venkataraman, G., Drummond, K., Turnbull, J., Toida, T., Linhardt, R., Biemann, K., and Sasisekharan, R. (2000a) Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site. Proc. Natl Acad. Sci. USA, 97, 10359-10364.
29. Shriver, Z., Sundaram, M., Venkataraman, G., Fareed, J., Linhardt, R., Biemann, K., and Sasisekharan, R. (2000b) Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Proc. Natl Acad. Sci. USA, 97, 10365-10370.
30. Shukla, D., Liu, J., Blaiklock, P., Shworak, N.W., Bai, X., Esko, J.D., Cohen, G.H., Eisenberg, R.J., Rosenberg, R.D., and Spear, P.G. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell, 99, 13-22.
31. Toida, T., Hileman, R.E., Smith, A.E., Vlahova, P.I., and Linhardt, R.J. (1996) Enzymatic preparation of heparin oligosaccharides containing anti-thrombin III binding sites. J. Biol. Chem., 271, 32040-32047.
32. Turnbull, J.E., Hopwood, J.J., and Gallagher, J.T. (1999) A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc. Natl Acad. Sci. USA, 96, 2698-2703.
33. Turpie, G.G., Gallus, A.S., and Hoek, J.A. (2001) A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N. Engl. J. Med., 344, 619-625.
34. Venkataraman, G., Shriver, Z., Raman, R., and Sasisekharan, R. (1999) Sequencing complex polysaccharides. Science, 286, 537-542.
35. Vives, R.R., Pye, D.A., Salmivirta, M., Hopwood, J.J., Lindahl, U., and Gallagher, J.T. (1999) Sequence analysis of heparan sulphate and heparin oligosaccharides. Biochem. J., 339, 767-773.
36. Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., and others. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis [see comments]. Nat. Med., 5, 793-802.
37. Yamada, S., Sakamoto, K., Tsuda, H., Yoshida, K., Sugiura, M., and Sugahara, K. (1999) Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin. Biochemistry, 38, 838-847.
38. Yamada, S., Yoshida, K., Sugiura, M., Sugahara, K., Khoo, K.H., Morris, H.R., and Dell, A. (1993) Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin. J. Biol. Chem., 268, 4780-4787.
39. 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydr. Res., 294, 15-27.